Isobutyl-N-(3-trifluormethylphenyl)-anthranilat | 67330-26-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: Isobutyl-N-(3-trifluormethylphenyl)-anthranilat
• 英文别名: 2-Methylpropyl 2-[3-(trifluoromethyl)anilino]benzoate
• CAS: 67330-26-1
• 化学式: C₁₈H₁₈F₃NO₂
• 分子量: 337.342
• InChiKey: CTSFRFZBHYFGKX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.9
• 重原子数：
  24
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  6

文献信息

• N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF
  申请人：Attali Bernard

  公开号：US20100137296A1

  公开（公告）日：2010-06-03

  Compounds that can be used as openers or blockers of voltage-dependent potassium channels, and which are useful in the treatment of conditions such as central or peripheral nervous system disorders through the modulation of potassium ion flux through voltage-dependent potassium channels and/or depressing or enhancing cortical and/or peripheral neuron activity, compositions containing same and methods utilizing same are disclosed. Also disclosed are modulators of voltage-dependent potassium channels, which exhibit blocking of a TRPV1 channel, and hence are useful in the treatment of TRPV1-related conditions.

  本发明揭示了可以用作电压依赖性钾离子通道的开放剂或阻断剂的化合物，其通过调节电压依赖性钾离子通道中的钾离子通量和/或抑制或增强皮质和/或外周神经元活动，在治疗中枢或外周神经系统疾病方面具有用途，以及包含该化合物的组合物和利用该化合物的方法。此外，本发明还揭示了电压依赖性钾离子通道的调节剂，其表现出对TRPV1通道的阻断作用，因此在治疗TRPV1相关疾病方面具有用途。
• US8765815B2
  申请人：——

  公开号：US8765815B2

  公开（公告）日：2014-07-01
• US9403756B2
  申请人：——

  公开号：US9403756B2

  公开（公告）日：2016-08-02
• [EN] N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE L'ACIDE N-PHÉNYLANTHRANILIQUE ET LEURS UTILISATIONS
  申请人：UNIV RAMOT

  公开号：WO2009037707A2

  公开（公告）日：2009-03-26

  ABSTRACT Compounds that can be used as openers or blockers of voltage-dependent potassium channels, and which are useful in the treatment of conditions such as central or peripheral nervous system disorders through the modulation of potassium ion flux through voltage-dependent potassium channels and/or depressing or enhancing cortical and/or peripheral neuron activity, compositions containing same and methods utilizing same are disclosed. Also disclosed are modulators of voltage-dependent potassium channels, which exhibit blocking of a TRPV1 channel, and hence are useful in the treatment of TRPV1-related conditions.